CARA (Computer Assisted Retinal Analysis)
Recall Z-0826-2022, part of FDA recall event 89715. See Diagnos's company page.
Diagnos Inc started this Class II device recall on Jan 11, 2022 (voluntary: firm initiated); FDA lists it as terminated, terminated Jun 18, 2024.
- Classification: Class II
- Started: Jan 11, 2022
- Status: Terminated
Retinal analysis system software has some features, based on artificial intelligence, that potentially lack appropriate market approval, so it is recommended to use a specific prior software version.
- Product
- CARA (Computer Assisted Retinal Analysis), Product ID: +B543CARA0/$$+7V4.7.2/16D202111179
- Quantity
- 1
- Lots and codes
- Software Version 4.7.2
- Distribution
- US: CA
- Recalling firm
- Diagnos Inc, Brossard, N/A, Canada
- How the firm notified
- Letter
- FDA classified
- Mar 25, 2022
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports